
Albertsons Companies (ACI) Stock Forecast & Price Target
Albertsons Companies (ACI) Analyst Ratings
Bulls say
Albertsons Companies exhibited a positive financial trajectory, with net sales revenue rising 2.08% year-over-year, increasing from $79.71 billion to $81.37 billion for the 12 months ending August 2025. The company's Q2 2026 revenue also reflected this growth, up 2% year-over-year to $18.92 billion, driven by strong demand across grocery, pharmacy, and digital sectors, alongside a significant 19% increase in pharmacy sales attributed to higher prescription volumes and rising health service integration. Additionally, the firm is projected to enhance its net sales revenue further, with anticipated growth to approximately $84.76 billion over the next twelve months, supported by its efficient operations and ongoing improvements in both in-store and online shopping experiences.
Bears say
Albertsons Companies has experienced a decline in key financial metrics, with gross margin decreasing by 61 basis points to 27%, largely attributed to a shift towards lower-margin pharmacy and digital segments, as well as increased digital fulfillment costs. Furthermore, the company's Net Operating Profit After Tax (NOPAT) fell by 3.53% year-over-year, and Economic Operating Cash Flow (EBITDAR) also declined by 2.33%, indicating challenges in sustaining profitability. Additionally, a decrease in Return on Capital (ROC) from 7.78% to 7.35% and a significant drop in Economic Profit (EP) of 29.28% further illustrate the underlying issues impacting Albertsons' financial health and future outlook.
This aggregate rating is based on analysts' research of Albertsons Companies and is not a guaranteed prediction by Public.com or investment advice.
Albertsons Companies (ACI) Analyst Forecast & Price Prediction
Start investing in Albertsons Companies (ACI)
Order type
Buy in
Order amount
Est. shares
0 shares